The interferon family as biomarkers of disease: renaissance of the innate immune system
Type I interferons as biomarkers in autoimmune diseases
The interferon signaling pathway genes as biomarkers of hepatitis C virus disease progression and response to treatment
IFN-λ and IgE-mediated allergic disease: a potential future role?
Interferons as biomarkers and effectors: lessons learned from animal models
MIGRAs: are they the new IGRAs? Development of monokine-amplified IFN-γ release assays
Proteomic biomarkers for psychiatric disorders: a progress update
News & Views in … Biomarkers in Medicine
Use of molecular diagnostic tests for peripheral neuropathy called into question
Proteomics used to identify potential biomarkers for dengue hemorrhagic fever
Noninvasive test for colorectal cancer risk now available in the USA
Virtual tool could aid detection of genetic mutations
Potential advances in the detection of circulating tumor cells with advent of new blood test
Research Highlights
Signaling molecule c-Met is a biomarker for favorable prognostic in Hodgkin lymphoma
New marker related to cancer neoangiogenesis: RGS5
Distinct soluble EGFR isoforms expressed in non-small-cell lung cancer cells compared with normal tissue
An interplay between epithelial–mesenchymal transition and reverse: gene patterns for tumorigenesis
HER3: a potential marker in colon cancer
An aromatase polymorphism (g.132810C>T) predicts risk of bisphosphonate-related osteonecrosis of the jaw
Efficacy and pharmacogenomic biomarkers in breast cancer
Gilbert syndrome: the UGT1A1 *28 promoter polymorphism as a biomarker of multifactorial diseases and drug metabolism
Monitoring early response to taxane therapy in advanced breast cancer with circulating tumor cells and [18F] 3´-deoxy-3´-fluorothymidine PET: a pilot study
Acknowledgements